RenovaCare Financials
| RCAR Stock | USD 0.0001 0.00 0.00% |
RenovaCare |
RenovaCare Stock Summary
RenovaCare competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, and Anebulo Pharmaceuticals. RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. Renovacare operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US75988J1060 |
| Business Address | 9375 East Shea |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.renovacareinc.com |
| Phone | 888 398 0202 |
| Currency | USD - US Dollar |
RenovaCare Key Financial Ratios
There are many critical financial ratios that RenovaCare's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that RenovaCare reports annually and quarterly.| Return On Equity | -5.69 | |||
| Return On Asset | -1.04 | |||
| Beta | 1.93 | |||
| Z Score | 16.1 |
RenovaCare Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RenovaCare's current stock value. Our valuation model uses many indicators to compare RenovaCare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RenovaCare competition to find correlations between indicators driving RenovaCare's intrinsic value. More Info.RenovaCare is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RenovaCare's earnings, one of the primary drivers of an investment's value.RenovaCare Systematic Risk
RenovaCare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. RenovaCare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on RenovaCare correlated with the market. If Beta is less than 0 RenovaCare generally moves in the opposite direction as compared to the market. If RenovaCare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one RenovaCare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of RenovaCare is generally in the same direction as the market. If Beta > 1 RenovaCare moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for RenovaCare Pink Sheet Analysis
When running RenovaCare's price analysis, check to measure RenovaCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovaCare is operating at the current time. Most of RenovaCare's value examination focuses on studying past and present price action to predict the probability of RenovaCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovaCare's price. Additionally, you may evaluate how the addition of RenovaCare to your portfolios can decrease your overall portfolio volatility.